Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/30/2000 | US6068995 Method for producing protein |
05/30/2000 | US6068994 Expression of heterologous proteins in yeast using dna encoding a fusion protein of ubiquitin and the protein which is cleaved in vivo by an endogenous ubiquitin-specific hydrolase to yield protein with authentic n-terminal |
05/30/2000 | US6068993 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
05/30/2000 | US6068992 Production of gonorrheal PI proteins and vaccines |
05/30/2000 | US6068991 High expression Escherichia coli expression vector |
05/30/2000 | US6068990 Proteins, their production and use |
05/30/2000 | US6068984 Separating hb15 prositive cells from population of unrelated cells by reacting antibody that specifically binds the extracellular, transmembrane or cytoplasmic domain of the glycoprotein, then isolating cells |
05/30/2000 | US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease |
05/30/2000 | US6068982 Ubiquitin conjugating enzymes |
05/30/2000 | US6068980 Using nitrogen-containing silicone which is silica support grafted with at least one nitrogen-containing hydrocarbon radical as compaction agent; protection against deoxyribonucleases |
05/30/2000 | US6068978 Apparatus and method for transfer of a fluid sample |
05/30/2000 | US6068977 Constructing clone library and long-range probe library from nucleic acid sample, hybridizing labeled probes to library, detecting labels, recording signals, computerized data processing with calibration information to construct map |
05/30/2000 | US6068976 Nucleotide sequences of control region of human obesity gene; for screening modulators of gene expression to treat hypertension, cardiovascular diseases, diabetes, infertility, obesity, anorexia, cachexia, and other eating disorders |
05/30/2000 | US6068973 Suppressing transmission of influenza a virus to cell by contacting cell with influenza virus peptide of specific sequence chosen by a computer algorithm |
05/30/2000 | US6068972 Screening by contacting microorganisms with organic solvent, determining expression of acr-like efflux pump gene locus, comparing to control, altered expression indicates activation of multiple antibiotic resistance phenotype |
05/30/2000 | US6068912 Platible non-metallic filler material for metallurgical screening paste |
05/30/2000 | US6068842 A polypeptide containing 66 kda protein of borrelia afzelli |
05/30/2000 | US6068840 Recombinant CDR-grafted and chimeric anti-IL-8 antibodies containing CDRs or the variable region from the mouse monoclonal antibody, WS-4 |
05/30/2000 | US6068837 Mesothelial cell gene therapy |
05/30/2000 | CA2676762A1 Peptides for the detection of hiv-1 group o |
05/30/2000 | CA2181566C Compositions and methods using unbound mpl receptor for stimulating platelet production |
05/30/2000 | CA2158274C Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
05/30/2000 | CA2142862C Method for inhibiting hiv replication using il-4 |
05/30/2000 | CA2119128C Alleviation of symptoms associated with inflammatory disease states |
05/30/2000 | CA2100791C Method of directing biosynthesis of specific polyketides |
05/30/2000 | CA2044630C Subtilisin mutants |
05/30/2000 | CA2026570C Method for production and purification of hepatitis b vaccine |
05/30/2000 | CA2019363C Dna and use thereof |
05/26/2000 | CA2252967A1 Protein fragments for use in protein targeting |
05/25/2000 | WO2000029846A2 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY |
05/25/2000 | WO2000029626A1 Rhadino virus lana acts in trans on a unit of rhadino virus dna to mediate efficient episome persistence |
05/25/2000 | WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
05/25/2000 | WO2000029620A1 Methods of facilitating vascular growth |
05/25/2000 | WO2000029618A1 Non-invasive detection of helicobacter pylori infection |
05/25/2000 | WO2000029617A2 Water-soluble luminescent quantum dots and bioconjugates thereof |
05/25/2000 | WO2000029616A1 Ligation assembly and detection of polynucleotides on solid-support |
05/25/2000 | WO2000029615A2 A whole-genome radiation hybrid map of the dog genome and use thereof for identifying genes of interest |
05/25/2000 | WO2000029614A1 Human prostaglandin receptors and methods of use thereof |
05/25/2000 | WO2000029613A1 Method for the quantitative detection of nucleic acids |
05/25/2000 | WO2000029611A2 Novel primers and probes for detecting hiv |
05/25/2000 | WO2000029610A1 Analytical system based upon spore germination |
05/25/2000 | WO2000029608A1 Transgenic animals as urinary bioreactors for the production of protein in the urine, recombinant dna construct for kidney-specific expression, and method of using same |
05/25/2000 | WO2000029607A1 Novel enhancers of plant growth |
05/25/2000 | WO2000029603A2 Low cost manufacture of oligosaccharides |
05/25/2000 | WO2000029602A1 Transfection of male germ cells for generation of selectable transgenic stem cells |
05/25/2000 | WO2000029601A1 A method for depopulating of vertebrate testis and for generation of transgenic species |
05/25/2000 | WO2000029600A1 Systemic viral/ligand gene delivery system and gene therapy |
05/25/2000 | WO2000029599A1 Viral vectors with late transgene expression |
05/25/2000 | WO2000029598A1 Novel recombinant adenovirus |
05/25/2000 | WO2000029597A2 Mutant genes encoding plant adp-glucose pyrophosphorylase and methods of use |
05/25/2000 | WO2000029596A1 Phosphonate metabolizing plants |
05/25/2000 | WO2000029595A1 Pad4 compositions and methods therefor |
05/25/2000 | WO2000029594A1 Root-specific promoter |
05/25/2000 | WO2000029593A1 Truncated nucleic acid sequences of the lettuce mosaic virus capsid gene and their use |
05/25/2000 | WO2000029592A2 Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
05/25/2000 | WO2000029591A1 Transgenic plant expressing maltogenic alpha-amylase |
05/25/2000 | WO2000029590A1 Method for identifying inhibitors of ipc synthase |
05/25/2000 | WO2000029588A1 Lysozyme fusion proteins in infections |
05/25/2000 | WO2000029587A1 Thermostable xylanases |
05/25/2000 | WO2000029586A2 Maize dna ligase i orthologue and uses thereof |
05/25/2000 | WO2000029585A1 Gene coding for an acyltranferase of oil seed rape and uses thereof |
05/25/2000 | WO2000029584A1 Antibody variants with higher binding affinity compared to parent antibodies |
05/25/2000 | WO2000029583A2 Immunoglobulin superfamily proteins |
05/25/2000 | WO2000029582A2 Cell surface receptor antigen vaccines |
05/25/2000 | WO2000029581A1 Human tslp dna and polypeptides |
05/25/2000 | WO2000029580A1 Calcium binding protein |
05/25/2000 | WO2000029579A1 Mammalian chondromodulin-like protein |
05/25/2000 | WO2000029578A1 Cloning and characterization of two m-rna transcription factors |
05/25/2000 | WO2000029577A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
05/25/2000 | WO2000029576A1 Lipocalin homologs |
05/25/2000 | WO2000029575A1 Novel human wnt gene |
05/25/2000 | WO2000029574A2 Inflammation-associated genes |
05/25/2000 | WO2000029573A2 Adenoviral vectors |
05/25/2000 | WO2000029572A1 Proteins maguin |
05/25/2000 | WO2000029571A1 Gene encoding novel transmembrane protein |
05/25/2000 | WO2000029570A1 Novel protein and utilization thereof |
05/25/2000 | WO2000029569A1 Methods of diagnosing or treating neurological diseases |
05/25/2000 | WO2000029566A1 Promoters for gene expression in the roots of plants |
05/25/2000 | WO2000029565A1 Methods for validating polypeptide targets that correlate to cellular phenotypes |
05/25/2000 | WO2000029564A2 Human glycine transporter type 2 |
05/25/2000 | WO2000029563A1 Nucleic acid isolation |
05/25/2000 | WO2000029562A1 Method of isolating plasmid dna |
05/25/2000 | WO2000029561A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
05/25/2000 | WO2000029560A1 α-AMYLASE VARIANTS |
05/25/2000 | WO2000029558A1 UDP-GALACTOSE: β-$I(N)-ACETYL-GLUCOSAMINE β1,3GALACTOSYLTRANSFERASES, β3GAL-T5 |
05/25/2000 | WO2000029557A1 A sensitive screening system for envelope-defective recombinant virus |
05/25/2000 | WO2000029555A1 Methods using genetic package display for detecting and identifying protein-protein interactions |
05/25/2000 | WO2000029553A1 Bioengineered tissue constructs and methods for producing and using them |
05/25/2000 | WO2000029551A2 Cells, culture methods, and their use in autologous transplantation therapy |
05/25/2000 | WO2000029550A2 Low oxygen culturing of central nervous system progenitor cells |
05/25/2000 | WO2000029549A2 Low oxygen culturing of cells |
05/25/2000 | WO2000029547A1 YfiI PSEUDOURIDINE SYNTHASE |
05/25/2000 | WO2000029448A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
05/25/2000 | WO2000029447A1 Rhamm antagonist antibodies |
05/25/2000 | WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
05/25/2000 | WO2000029445A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
05/25/2000 | WO2000029444A1 Generation of antibodies using polynucleotide vaccination in avian species |
05/25/2000 | WO2000029443A1 Contraceptive antibody vaccines |
05/25/2000 | WO2000029442A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid |
05/25/2000 | WO2000029441A1 Novel g protein-coupled receptor protein, its dna and ligand thereof |